semaglutide and dementia Frontiers New study highlights potential of

Retatrutide is studied as a triple agonist at the GLP-1, GIP, and glucagon receptors

Bewick, selective ablation of peptide YY cells in adult mice reveals their role in beta cell survival

If you reach maximum dose without noticeable appetite effects, this may indicate you are a poor responder or other factors are interfering with the medication effectiveness

Early studies, such as a small randomized Phase II pancreatic cancer trial from the University of Iowa published in Redox Biology (2024), have reported encouraging survival signals when vitamin C was added to chemotherapy, but these findings need confirmation in larger trials

pick ones with live, active cultures

FDA Adverse Event Reporting System (FAERS) data from 2022 to 2025 includes 89 reports explicitly mentioning early dosing of tirzepatide